Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary UpdateDaniela Prosperi, Alberto Signore, Guido Gentiloni Silveri et al.|Journal of Clinical Medicine|2022Cited by 19
Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of TherapyAlberto Signore, Paolo Marchetti, Chiara Lauri et al.|Cancers|2020Cited by 14
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Marta Benavent Viñuales et al.|BMC Cancer|2025Cited by 7
Therapy of NET with radiolabeled SST analogsAlberto Signore, Francesco Panzuto, Daniela Prosperi et al.|Nuclear Medicine and Molecular Imaging|2022Cited by 1
Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Virginia Pubul et al.|BMC Cancer|2026Cited by 0